Cresset Asset Management’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,970
| Closed | -$66.5K | – | 2081 |
|
|
2024
Q2 | $66.5K | Sell |
4,970
-4,713
| -49% | -$63K | ﹤0.01% | 1936 |
|
|
2024
Q1 | $449K | Buy |
9,683
+2,012
| +26% | +$93.4K | ﹤0.01% | 1368 |
|
|
2023
Q4 | $519K | Buy |
7,671
+337
| +5% | +$22.8K | ﹤0.01% | 1194 |
|
|
2023
Q3 | $531K | Buy |
7,334
+534
| +8% | +$38.7K | ﹤0.01% | 1115 |
|
|
2023
Q2 | $506K | Buy |
6,800
+5,988
| +737% | +$446K | ﹤0.01% | 1143 |
|
|
2023
Q1 | $43.2K | Sell |
812
-11
| -1% | -$585 | ﹤0.01% | 790 |
|
|
2022
Q4 | $55.6K | Sell |
823
-139
| -14% | -$9.4K | ﹤0.01% | 684 |
|
|
2022
Q3 | $120K | Buy |
962
+625
| +185% | +$78K | ﹤0.01% | 828 |
|
|
2022
Q2 | $32K | Buy |
+337
| New | +$32K | ﹤0.01% | 919 |
|